Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: novel and potent antiangiogenic molecule

July 21, 1999

Novel paclitaxel analogues under evaluation at Bristol-Myers

July 21, 1999

Abgenix files IND for ABX-EGF

July 21, 1999

Hodgkin's lymphoma cell discovered by international team

July 20, 1999

Preclinical activity, current status of potent P-glycoprotein inhibitor discussed at congress

July 19, 1999

New cytoprotective compound that acts by inhibiting PARP activity developed at N-Gene

July 19, 1999

PDT with Photofrin cleared in Canada for certain forms of lung cancer

July 19, 1999

Triazine-based inhibitors of angiogenesis designed by Abbott researchers

July 19, 1999

MPBX's enhancement of doxorubicin activity examined in P388 leukemia

July 19, 1999

Interim data released for NeoRx's STR product in multiple myeloma

July 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...